Amit Sachdev insider trades

Open-market stock purchases and sales by Amit Sachdev, EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc / MA, from SEC Form 4 filings since Feb 4, 2010.

Recent trades

DateStockTradeValue
Jul 21, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Feb 25, 2026VRTX Vertex Pharmaceuticals Inc / MASold$898K
Feb 24, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$736K
Feb 19, 2026VRTX Vertex Pharmaceuticals Inc / MASold$427K
Feb 19, 2026VRTX Vertex Pharmaceuticals Inc / MASold$1.3M
Feb 19, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Feb 19, 2026VRTX Vertex Pharmaceuticals Inc / MASold$861K
Feb 19, 2026VRTX Vertex Pharmaceuticals Inc / MASold$4.8M
Feb 19, 2026VRTX Vertex Pharmaceuticals Inc / MASold$9.2M
Feb 19, 2026VRTX Vertex Pharmaceuticals Inc / MASold$3.4M
Feb 19, 2026VRTX Vertex Pharmaceuticals Inc / MASold$5.5M
Feb 19, 2026VRTX Vertex Pharmaceuticals Inc / MASold$2M
Feb 19, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$1M
Feb 13, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$1.7M
Feb 10, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$964K
Jan 22, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Jan 22, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—

Companies traded

  • VRTX Vertex Pharmaceuticals Inc / MA: 229 sales, last Jul 21, 2026
  • EIGR Eiger BioPharmaceuticals, Inc: other filings, last Mar 1, 2023

Get free alerts when Amit Sachdev files a new trade →